네오팜

092730KOSDAQ

68.8 / 100

Reference Date: 2026-09-08

Financial Score26.5 / 40

News Sentiment21.3 / 25

Momentum11.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Rose 5.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Neoparm operates various cosmetics brands, including its flagship 'Atopear', and achieved sales of 132.1 billion KRW and net profit of 27.9 billion KRW in 2025. The company leverages its proprietary MLE formulation technology, which enhances skin barrier function, securing market competitiveness. 'Atopear' has maintained the top position in the sensitive skincare category for 19 consecutive years according to the K-BPI survey.

Number of Employees

192people

Average Salary

63.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.56Industry Average 15.005.0Point

In line with industry avg

PBR

1.83Industry Average 1.201.0Point

1.5x industry avg (risky)

ROE

14.95Industry Average 8.005.5Point

1.9x industry avg (good)

Debt Ratio

0.73Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20257.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲16.8% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲7.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 14.7% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
"화장품 넘어 피부과학으로" 뷰티업계 'K-더마' 영토 확장
네오팜의 피부과학 전략 확장으로 전문 뷰티 시장 확대 기대
Positive
[클릭 e종목]"네오팜, 분기 역대 최고매출…목표가 상향"
LS증권의 목표주가 상향 및 매수 의견으로 네오팜의 분기 매출이 역대 최고를 기록하며 긍정적인 시장 반응을 보임.

Detailed Momentum

52-week position6.0Point

52w upper range (68%)

Current 22,350Won52-week high 25,45052-week low 15,760

1-month return4.0Point

1m +5.67% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최2026-08-24
Neutral반기보고서 (2026.06)2026-08-14